Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan

Abstract Background As more patients turn to complementary therapies (CTs) alongside conventional medicine, the lack of communication between patients who use CTs and their conventional healthcare professionals (HCPs) can pose significant risks, including the potential for serious drug interactions....

Full description

Saved in:
Bibliographic Details
Main Author: Hsiao-Yun Chang
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:https://doi.org/10.1186/s12906-025-04897-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850277875634143232
author Hsiao-Yun Chang
author_facet Hsiao-Yun Chang
author_sort Hsiao-Yun Chang
collection DOAJ
description Abstract Background As more patients turn to complementary therapies (CTs) alongside conventional medicine, the lack of communication between patients who use CTs and their conventional healthcare professionals (HCPs) can pose significant risks, including the potential for serious drug interactions. Purpose To explore the factors influencing the disclosure of CTs use to conventional HCPs. Methods A cross-sectional survey design was employed to enroll 307 outpatients diagnosed with diabetes from both the northern and southern regions of Taiwan, covering the period from October 2022 to March 2023. The survey questionnaire included demographics, the patterns of CTs use, the experiences of CTs use, the Understanding the Benefit-Risks of CTs Use Scale, and the Diabetes Empowerment Scale. The data were analyzed using IBM SPSS Statistics version 28.0. Results Only one-third of outpatients with diabetes disclosed their use of CTs to conventional HCPs. Several factors emerged as influential in this disclosure: understanding the benefits and risks of CTs use (OR = 1.10), the reasons for initial CTs use (OR = 1.58), integration of both conventional and complementary medicines (OR = 15.03), and the use of manipulative-based therapies (OR = 6.82). Conclusion Understanding the factors that influence the disclosure of CTs use is essential for conventional HCPs. This understanding allows them to identify outpatients who may hesitate to disclose their CTs use and ensures they have a comprehensive understanding of their patients' CTs use, thereby facilitating effective communication.
format Article
id doaj-art-6cfde0299f174d4f8a8a7cbb8cfa9aae
institution OA Journals
issn 2662-7671
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj-art-6cfde0299f174d4f8a8a7cbb8cfa9aae2025-08-20T01:49:42ZengBMCBMC Complementary Medicine and Therapies2662-76712025-05-012511910.1186/s12906-025-04897-9Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in TaiwanHsiao-Yun Chang0Department of Nursing, Chang Gung University of Science and TechnologyAbstract Background As more patients turn to complementary therapies (CTs) alongside conventional medicine, the lack of communication between patients who use CTs and their conventional healthcare professionals (HCPs) can pose significant risks, including the potential for serious drug interactions. Purpose To explore the factors influencing the disclosure of CTs use to conventional HCPs. Methods A cross-sectional survey design was employed to enroll 307 outpatients diagnosed with diabetes from both the northern and southern regions of Taiwan, covering the period from October 2022 to March 2023. The survey questionnaire included demographics, the patterns of CTs use, the experiences of CTs use, the Understanding the Benefit-Risks of CTs Use Scale, and the Diabetes Empowerment Scale. The data were analyzed using IBM SPSS Statistics version 28.0. Results Only one-third of outpatients with diabetes disclosed their use of CTs to conventional HCPs. Several factors emerged as influential in this disclosure: understanding the benefits and risks of CTs use (OR = 1.10), the reasons for initial CTs use (OR = 1.58), integration of both conventional and complementary medicines (OR = 15.03), and the use of manipulative-based therapies (OR = 6.82). Conclusion Understanding the factors that influence the disclosure of CTs use is essential for conventional HCPs. This understanding allows them to identify outpatients who may hesitate to disclose their CTs use and ensures they have a comprehensive understanding of their patients' CTs use, thereby facilitating effective communication.https://doi.org/10.1186/s12906-025-04897-9DiabetesComplementary and alternative medicineDisclosureComparison
spellingShingle Hsiao-Yun Chang
Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan
BMC Complementary Medicine and Therapies
Diabetes
Complementary and alternative medicine
Disclosure
Comparison
title Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan
title_full Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan
title_fullStr Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan
title_full_unstemmed Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan
title_short Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan
title_sort breaking the silence factors influencing complementary therapy disclosure among diabetic outpatients in taiwan
topic Diabetes
Complementary and alternative medicine
Disclosure
Comparison
url https://doi.org/10.1186/s12906-025-04897-9
work_keys_str_mv AT hsiaoyunchang breakingthesilencefactorsinfluencingcomplementarytherapydisclosureamongdiabeticoutpatientsintaiwan